Artículos de revistas
Piperacillin/tazobactam-induced neurotoxicity in a hemodialysis patient: a case report
Fecha
2015Registro en:
Hemodialysis International, v. 19, n. 1, p. 143-145, 2015.
1492-7535
10.1111/hdi.12194
7862086981190726
5496411983893479
7862086981190726
5496411983893479
7862086981190726
5496411983893479
4923203168446615
0000-0003-4979-4836
Autor
Universidade Estadual Paulista (Unesp)
Institución
Resumen
Antibiotics are potentially a cause of neurotoxicity in dialysis patients, the most common are thebeta-lactams as ceftazidime and cefepime, and few cases have been reported after piperacillin/tazobactam use. This report presents a case of a hypertensive and diabetic 67-year-old woman inregular hemodialysis, which previously had a stroke. She was hospitalized presenting pneumonia,which was initially treated with cefepime. Two days after treatment, she presented dysarthria, lefthemiparesis, ataxia, and IX and X cranial nerves paresis. Computed tomography showed no acutelesions and cefepime neurotoxicity was hypothesized, and the antibiotic was replaced bypiperacillin/tazobactam. The neurologic signs disappeared; however, 4 days after with piperacillin/tazobactam treatment, the neurological manifestations returned. A new computed tomographyshowed no new lesions, and the second antibiotic regimen withdrawn. After two hemodialysissessions, the patient completely recovered from neurological manifestations. The patient presentedsequentially neurotoxicity caused by two beta-lactams antibiotics. This report meant to alertclinicians that these antibiotics have dangerous neurological effects in chronic kidney diseasepatients.